Clinical trials testing the Benefit/Risk ratio of Investigational Medicinal Products (IMPs) in the European Union/European Economic Area (EU/EEA) are governed currently by Directive 2001/20/EC [1], defining the requirements for the conduct of clinical trials in the EU. The Directive became effective...
Quality by Design can impart strong added value to the overall control strategy of your process and product. While this can take a certain degree of up-front time and cost input, the quality dividends in terms of robustly delivering a process and product that more consistently meets quality ...